학회소개 학회지검색 학술행사 온라인 평생교육 CME 아카데믹 리소스 회원공간
  • 인사말
  • 학회 역사
  • 역대 회장단
  • 임원 및 위원회
  • 지회
  • 회칙
  • 회원가입 안내
  • 공지사항
  • 뉴스레터
  • 보도자료
  • 사무국 안내
  • CMH 검색
  • 과거 학회지
  • 온라인 논문투고
  • 논문투고규정(영문)
  • 논문투고규정(국문)
  • 대한간학회 일정
  • 행사일정
  • 지회 연수교육 일정
  • 학술연구비 및 수상내역
  • 교육과정 안내
  • 수강 규정
  • 수강 신청 안내
  • 교육과정 보기
  • 나의 교육수강
  • 교육자료실
  • 학술 강좌
  • 진료 가이드라인
  • Update Treatment
  • 간질환 백서
  • Liver Disease Calculator
  • 의학용어검색
  • 관련 사이트
  • 건의함
  • 열린 마당
  • 요양급여 정보
  • 사진자료
  • 회원검색
  • 서식 다운로드
  • 간행물 소개
  • My page
  • 이사회 공간
학술 강좌
Home > 아카데믹 리소스 > 학술 강좌
2017
The Liver Week 2017
CME 표시된 자료는 CME 메뉴를 통해 보실 수 있습니다.
일시 2017년 06월 22일(목)~24일(토)
장소 인천 그랜드 하얏트 호텔
주제 Striving for a Complete Cure of Liver Diseases
표지 및 목차
Basic Science Workshop 1. Nuclear Receptors in Liver Disease
Nuclear Receptors in Liver Disease: Basic Concept
Hueng-Sik Choi (Chonnam National Univ.)
Nuclear Receptor Controls Hepatic Lipid Homeostasis to Protect against Nonalcoholic Fatty Liver Disease
Sungsoon Fang (Yonsei Univ.)
Nuclear Receptors in Hepatocellular Carcinoma
Raffaella Maria Gadaleta (Univ. of Bari, Italy)
Basic Science Workshop 2. Gut Microbiota in Liver Disease
Microbiota, a Key Player in Alcoholic Liver Disease
Anne-Marie Cassard (INSERM, France)
Gut Microbiota in Nonalcoholic Steatohepatitis
Manuela Neuman (Univ. of Toronto, Canada)
Microbiome in Liver Cirrhosis
Moon Young Kim (Yonsei Univ. Wonju)
Clinical Science Methodology Workshop 1. How to Publish My Research: Study Design, Writing, and Revision (*K)
Randomized Controlled Trial
Jeong-Hoon Lee (Seoul National Univ.)
Retrospective Clinical Study
Dong Hyun Sinn (Sungkyunkwan Univ.)
Basic Research
Ki Tae Suk (Hallym Univ.)
Clinical Science Methodology Workshop 2. How to Accept a Paper
Manuscript Review 1
Eliseo Guallar (Johns Hopkins Univ., USA)
Manuscript Review 2
Young-Suk Lim (Univ. of Ulsan)
Symposium 1. Direct-Acting Antivirals for Difficult to Treat Chronic Hepatitis C Patients
Direct-Acting Antivirals in Renal Failure
Edward Gane (Univ. of Auckland, New Zealand)
Baseline RAS Test: Clinical Practice
Kazuaki Chayama (Hiroshima Univ., Japan)
Direct-Acting Antivirals in Decompensated Cirrhosis, Pre and Post Liver Transplantation
Paul Y Kwo (Stanford Univ., USA)
Management of Chronic Hepatitis C Patients with Direct-Acting Antiviral Failure
Norihiro Furusyo (Kyushu Univ., Japan)
Plenary Session 1
Plenary Session 1
Jae-Won Joh, Dong-Sup Yoon, Jin Mo Yang, Jinsil Seong (Sungkyunkwan Univ., Yonsei Univ., The Catholic Univ. of Korea, Yonsei Univ.)
Special Lecture 1. Hepatitis C Virus
Pan-Genotypic Hepatitis C Virus Treatment Strategies for Na?ve and Direct-Acting Antiviral Failure Patients
Paul Y Kwo (Stanford Univ., USA)
Clinical Hepatology Update (*K)
Hepatitis B Virus Treatment: 2017 Newcomers
Sang Hoon Ahn (Yonsei Univ.)
Hepatitis C Virus Treatment: 2017 Newcomers
Ki Tae Yoon (Pusan National Univ.)
Hepatocellular Carcinoma: 2017 Newcomers
Jeong Won Jang (The Catholic Univ. of Korea)
Liver Cirrhosis: Rifaximin, Recent Clinical Role in Advanced Cirrhosis
Yeon Seok Seo (Korea Univ.)
KASL & KLTS Joint Symposium. Transplantation
Liver Transplantation in Patients with Alcoholic Liver Disease
Julie Heimbach (Mayo Clinic, USA)
The Quality of Life of Hepatocellular Carcinoma Patients according to Treatment Strategies
Jong Man Kim (Sungkyunkwan Univ.)
Perioperative Care of Severely Ill Patients: Acute Kidney Injury and Hepatic Encephalopathy
Eunmi Gil (Sungkyunkwan Univ.)
The Effects of Sarcopenia on Liver Transplantation
Hee Yeon Kim (The Catholic Univ. of Korea)
Symposium 2. Current Advances in Nonalcoholic Fatty Liver Disease
Novel Function of Hepatic Macrophage in Nonalcoholic Fatty Liver Disease
Won-Il Jeong (KAIST)
Genetic Susceptibility and Disease Severity
Vincent Wong (The Chinese Univ. of Hong Kong, Hong Kong)
Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Etsuko Hashimoto (Etsuko Hashimoto)
Nonalcoholic Fatty Liver Disease Treatment: Candidate Drug Target in Next 10 Years
Yoon Jun Kim (Seoul National Univ.)
KLTS & KAHBPS Joint Symposium. Deceased Donor Liver Transplantation in the MELD Era (*K)
Liver Transplantation in Korea based on Big Data
Jinkyeong Park (Sungkyunkwan Univ.)
Deceased Donor Liver Transplantation according to MELD Allocation
Myoung Soo Kim (Yonsei Univ.)
Changes in Hospitals in the MELD Era (1): Asan Medical Center
Shin Hwang (Univ. of Ulsan)
Changes in Hospitals in the MELD Era (2): Pusan National Univ. Yangsan Hospital
Je Ho Ryu (Pusan National Univ.)
Changes in Hospitals in the MELD Era (3): Severance Hospital
Myoung Soo Kim (Yonsei Univ.)
Changes in Hospitals in the MELD Era (4): Chonbuk National Univ. Hospital
Hee Chul Yu (Chonbuk National Univ.)
KLTS Symposium 1. Review of Immunosuppressants (*K)
How Readily Available Are mTOR Inhibitors?
Dong-Hwan Jung (Univ. of Ulsan)
The Optimal Drug Concentration of Tacrolimus after Liver Transplantation
Jong Man Kim (Sungkyunkwan Univ.)
MMP Monotherapy for Long-Term Survivors
Young Seok Han (Kyungpook National Univ.)
How Can Anti-Thymocyte Globulin Be Used in a Liver Transplant Recipient?
Jae Geun Lee (Yonsei Univ.)
KLTS Symposium 2. Vaccine Strategies for Liver Recipients (*K)
Before and After Liver Transplantation
Sang Il Kim (The Catholic Univ. of Korea)
Travel Vaccination in Liver Recipients
Young Eun Ha (Sungkyunkwan Univ.)
Pediatric Vaccinations in Liver Recipients
Seak Hee Oh (Univ. of Ulsan)
Health Policy Forum. Future Hepatology (*K)
A Rational Understanding of the Fourth Industrial Revolution and Artificial Intelligence
Kyoung Jun Lee (Kyung Hee Univ.)
Watson for Oncology-Korean Experience and Future
Young Bo Kim (Gachon Univ.)
Reading Images by Artificial Intelligence: Where Are We?
Kyoung Doo Song (Sungkyunkwan Univ.)
Practice of Liver Disease Research Using Big Data of HIRA
Dae Won Jun (Hanyang Univ.)
KAHBPS Symposium 1. Klatskin Tumor: New Frontiers in Treatment
Anterior Approach for Perihilar Cholangiocarcinoma
Masakazu Yamamoto (Tokyo Women's Medical Univ., Japan)
Resection-based Strategy for Type IV Perihilar Cholangiocarcinoma De Novo’
Tomoki Ebata (Nagoya Univ., Japan)
Neoadjuvant Chemoradiotherapy followed by Liver Transplantation for Hilar Cholangiocarcinoma
Julie K. Heimbach (Mayo Clinic, USA)
Photodynamic Therapy in Patients with Advanced Hilar Cholangiocarcinomas
Young Koog Cheon (Konkuk Univ.)
Early Morning Workshop 1. How to Do Good Epidemiologic Research
Early Morning Workshop 1. How to Do Good Epidemiologic Research
Eliseo Guallar, Hyung Joon Kim, Geum-Youn Gwak (Johns Hopkins Univ., USA, Chung-Ang Univ., Sungkyunkwan Univ.)
Early Morning Workshop 2. HCV: Optimized Management of HCV in Various Clinical Condition
Early Morning Workshop 2. HCV: Optimized Management of HCV in Various Clinical Condition
Paul Y Kwo, Oidov Baatarkhuu, Jung Il Lee (Stanford Univ., USA, Mongolian National Univ. of Medical Sciences, Mongolia, Yonsei Univ.)
KLTS Coordinator Session: Current Liver Transplantation in Korea (*K)
Recent Update of Antiviral Agents in Liver Transplantation
Dong Hyun Sinn (Sungkyunkwan Univ.)
Real Practice in the MELD Era
Seung Heui Hong (Samsung Medical Center)
Care in Liver Recipients
Hea Seon Ha (Asan Medical Center)
KASL-KAHBPS-KLCA-KLTS Joint Symposium. Hepatocellular Carcinoma
Primary vs. Salvage Liver Transplantation after Resection of Hepatocellular Carcinoma
Kwang Woong Lee (Seoul National Univ.)
Current and Emerging Biomarkers Reflecting Cancer Biology in Hepatocellular Carcinoma
Richard Finn (UCLA, USA)
Evolving Therapies for Advanced Hepatocellular Carcinoma in Post-Sorafenib Era
Joong-Won Park (National Cancer Center Korea)
Does the Pathology Show the Risk of Recurrence?
Young Nyun Park (Yonsei Univ.)
Plenary Session 2
Plenary Session 2
Edward Gane, Byung Chul Yoo, Kwang-Hyub Han, Young-Hwa Chung (Univ. of Auckland, New Zealand, Konkuk Univ., Yonsei Univ, Univ. of Ulsan)
Special Lecture 2. Hepatocellular Carcinoma
Genetic Optimization of Liver Cancer Therapy
Jesper B. Andersen (Univ. of Copenhagen, Denmark)
Alcoholic Liver Disease Symposium
The Role of Scoring Systems in Severe Alcoholic Hepatitis
Hee Yeon Kim (The Catholic Univ. of Korea)
Gut Microbiota Modulation in Alcoholic Liver Disease Treatment
Ki Tae Suk (Hallym Univ.)
Regenerative Treatment of Alcoholic Liver Disease
Won Kim (Seoul National Univ.)
The Management of Alcohol Abuse and its Complications
Dae Hee Choi (Kangwon National Univ.)
Hepatitis B Virus Symposium
Current Status of Hepatitis B Virus Therapy: Why Do We Need New Treatment?
Jin-Wook Kim (Seoul National Univ.)
When and with Whom to Stop NUC Therapy?: Evolving Concepts
Hyung Joon Yim (Korea Univ.)
Emerging Therapy for Hepatitis B Virus
Chang Wook Kim (The Catholic Univ. of Korea)
KAHBPS Special Lecture
Complex Liver Resection Using Total Vascular Exclusion
Daniel Azoulay (Henri-Mondor Hospital, France)
KAHBPS Symposium 2. Complex Liver Surgery for Unusual Indications (with Video)
Liver Transplantation Using the Whole or Partial Liver for Unresectable Colorectal Liver Metastases
Pal-Dag Line (Univ. of Oslo, Norway)
Extracorporeal Hepatic Venous Bypass for Resection of Tumor with Hepatic Vein Invasion
Dong-Sik Kim (Korea Univ.)
Liver Resection with Complex Vascular Reconstruction
Daniel Azoulay (Henri-Mondor Hospital, France)
Various Options for Staged Hepatectomy: Preoperative Portal Vein Embolization, Intraoperative Portal Vein Ligation, andAssociating Liver Partition and Portal Vein Ligation for Staged Hepatectomy
Gi Hong Choi (Yonsei Univ.)
KLCA Symposium 1. Non-Surgical Approaches for Early Hepatocellular Carcinoma (HCC):Beyond Guidelines
High-Dose Hypofractionated Proton Beam Therapy for Small-Size HCC
Theodore S. Hong (Harvard Univ., USA)
Stereotactic Body Radiotherapy: A Multifaceted Tool
Laura Dawson (Univ. of Toronto, Canada)
Radiofrequency and Microwave Ablation: Expansion of Indication
Hyunchul Rhim (Sungkyunkwan Univ.)
KLCA Symposium 2. Evolving and Unresolved Issues: Surveillance and Prevention
Individualized Screening Strategies according to HCC Risk: in Whom and How?
Do Young Kim (Yonsei Univ.)
Optimal Imaging Surveillance of HCC: US vs. MRI
Young-Suk Lim (Univ. of Ulsan)
Direct Acting Antiviral Agents for Hepatitis C Virus after Resection of HCC: Friend or Foe?
Jaeyoun Cheong (Ajou Univ.)
Prevention of NASH-Associated HCC
Vincent Wong (The Chinese Univ. of Hong Kong, Hong Kong)
KLCA Symposium 3. Emerging Therapy for Advanced HCC
Application of Proton Beam Therapy for Advanced HCC
Theodore S. Hong (Harvard Univ., USA)
Liver-Directed CCRT for Locally Advanced HCC
Jinsil Seong (Yonsei Univ.)
Emerging Multi-Kinase Inhibitors for Advanced HCC
Richard Finn (UCLA, USA)

(우.04158) 서울시 마포구 마포대로 53, A동 1210호
(구주소: (우.121-784) 서울시 마포구 도화동 559 마포트라팰리스 A동 1210호)
전화 02)703-0051 팩스 02)703-0071 이메일 kasl@kams.or.kr
Copyright(c) by the Korean Association for study of the Liver. All rights reserved.
COUNTER
TODAY : 846
TOTAL : 490446